Navigation Links
Mylan Launches Generic Version of Lipitor®
Date:5/29/2012

PITTSBURGH, May 29, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Laboratories Limited (formerly Matrix Laboratories Limited) has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Atorvastatin Calcium Tablets, 10 mg, 20 mg, 40 mg and 80 mg. Atorvastatin Calcium is the generic version of Pfizer's Lipitor® Tablets, which are indicated as an adjunct to diet in patients with primary hypercholesterolemia and mixed dyslipidemia to reduce elevated total cholesterol, LDL, triglycerides and to increase HDL cholesterol.

Mylan CEO Heather Bresch said: "We are very pleased to have received final approval for our ANDA for generic Lipitor®, the most widely prescribed drug in U.S. history. Through Mylan's launch of Atrovastatin Calcium Tablets, we look forward to be able to offer our customers, the American consumer and the U.S. government significant savings and expanded access to this important product."

Lipitor had U.S. sales of $8.1 billion for the twelve months ending March 31, 2012, according to IMS Health. Mylan is shipping this product immediately.

Currently, Mylan has 171 ANDAs pending FDA approval representing $84 billion in annual sales, according to IMS Health. Thirty-eight of these pending ANDAs are potential first-to-file opportunities, representing $25.5 billion in annual brand sales, for the 12 months ending Dec. 31, 2011, according to IMS Health.

Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service a habit, do what's right, not what's easy and impact the future through passionate global leadership. We offer a growing portfolio of mor
'/>"/>

SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R)
2. Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment Sinemet(R)
3. Mylan Schedules Third Quarter 2009 Financial Results Conference Call and Live Webcast
4. Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
5. Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)
6. Mylan Receives Approval for Generic Version of GoLytely(R)
7. Mylan Declares Quarterly Preferred Stock Dividend
8. Mylan Pre-Pays All Scheduled 2011 Term-Loan Borrowings
9. Mylan Confirms First-to-File Patent Challenge Relating to Vytorin(R) Cholesterol Medication
10. Mylans President of Europe, Middle East and Africa Elected President of European Generic Medicines Association
11. Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories New Drug Application (NDA) for Efavirenz Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 18, 2013  Actavis, Inc. (NYSE: ACT ) ... the U.S. Securities and Exchange Commission (SEC) a registration statement ... Warner Chilcott plc (NASDAQ: WCRX ), ... Warner Chilcott (the "Form S-4"). As previously ... have entered into a definitive agreement pursuant to which ...
(Date:6/18/2013)... ROCKY HILL, Conn. , June 18, 2013 ... many past clients of Alliance Seating and Mobility, ... now unable to access timely repair. This appears ... and a dramatic reduction of field service employees.  ... Unfortunately a great many of these clients ...
(Date:6/18/2013)... ANDOVER, Mass. , June 18, 2013 ... announced the company was named Overall Performance Leader in ... Medical Equipment & Infrastructure report. Philips also received Best ... of its imaging products: Ingenuity Core 128 Computed ... iE33 ultrasound and PageWriter TC70 cardiograph. The annual Best ...
Breaking Medicine Technology:Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 2Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 3Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 4Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 5Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 6Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 7Philips Named 2013 Overall Performance Leader In Imaging Equipment By KLAS 2
... 2012  Based on its recent analysis of the ... recognizes Sensear with the 2012 North American Frost ... its "high-noise communication" devices, including earplugs and earmuffs ... still enabling the user to remain fully aware ...
... Carla Corkern, Chief Executive Officer at Talyst , was ... recognizes entrepreneurs whose ingenuity, hard work and perseverance have created ... originated in 1986 and has grown to 26 programs in ... the world. "Talyst is a leader in ...
Cached Medicine Technology:Frost & Sullivan Recognizes Sensear for Innovative and Effective Product Differentiation in the PPE Market 2Frost & Sullivan Recognizes Sensear for Innovative and Effective Product Differentiation in the PPE Market 3Frost & Sullivan Recognizes Sensear for Innovative and Effective Product Differentiation in the PPE Market 4
(Date:6/18/2013)... Case Medical Center clinical researchers have launched an ... will evaluate the ability of a patient,s own ... stage peripheral arterial disease (PAD). , Led ... at University Hospitals Case Medical Center,s Harrington Heart ... Case Western Reserve University School of Medicine, the ...
(Date:6/18/2013)... at Case Western Reserve University,s College of Arts ... made available avatarsvirtual patientsto train speech-language pathologists. ... to evaluate speech-language disorders to practice using an ... because a diagnosis doesn,t have to be made ... studying to become speech-language pathologists have previously relied ...
(Date:6/18/2013)... have discovered and mapped the signaling network between two ... could cut off cancer cell growth at its starting ... University of Texas MD Anderson Cancer Center reported the ... cancer drug target, and MCM7, a protein vital to ... issue of Cancer Cell . , "MCM7 overexpression ...
(Date:6/18/2013)... Belleville, Ill. (PRWEB) June 18, 2013 More ... older are living with HIV/AIDS, according to the Centers for ... don’t know they are infected. In support of National HIV ... Social Security Disability Insurance (SSDI) representation, the CDC ... HIV testing. , The CDC reports about 50,000 new ...
(Date:6/18/2013)... CA (PRWEB) June 18, 2013 The July ... “The Cheater’s Guide to Getting Beach Ready,” offers a list ... to look their best in a bathing suit this summer. ... skin firming , smoothing cellulite , and more. ... Simon Ourian, Medical Director of Epione Beverly Hills, “though I ...
Breaking Medicine News(10 mins):Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2Health News:SimuCase avatars advance speech-language pathology training 2Health News:Scientists catch EGFR passing a crucial message to cancer-promoting protein 2Health News:Allsup Observes National HIV Testing Day June 27 2Health News:Allsup Observes National HIV Testing Day June 27 3Health News:Skin Care – Getting Your Body Beach Ready 2
... , , WEDNESDAY, Nov. 7 (HealthDay News) -- Brain development is ... shows. , The slowdown in brain development is similar to ... Babies who require heart surgery have long been known to ... the surgery or other factors has been in debate. , ...
... Cost, language barriers often to blame, study finds , ... statin drugs are known to be effective, many patients ... factors may be to blame. , In their study, ... They found that statin discontinuation rates among more than ...
... NEWPORT NEWS, Va., Nov. 7 This past ... Opposing Compact Gamma,Cameras" were presented at the Nuclear ... The goal of the laboratory study was ... camera system in a configuration in which,the two ...
... Health Informatics, From,Foundations to Applications to Policy, ... American Medical,Informatics Association (AMIA) 31st Annual Symposium, ... in biomedical and health,informatics starts Friday. Experts ... privacy and security of electronic health information,transparency ...
... WASHINGTON, Nov. 7 Today, the release ... Reduce Teen,Pregnancy and Sexually Transmitted Disease, a report ... adolescent health, confirmed, once,again, that the $1.5 billion ... waste of taxpayer money., The report, commissioned ...
... First to Taste Missy Chase Lapine,s New Kid-Friendly, Kid-Healthy Dishes, Now Added to the ... Cynthia Sparer, executive director, Morgan Stanley ... member Family Advisory Council, Morgan ... Missy Chase Lapine, Patients and ...
Cached Medicine News:Health News:Heart Defects Can Delay Baby's Brain Development 2Health News:Heart Defects Can Delay Baby's Brain Development 3Health News:Heart Defects Can Delay Baby's Brain Development 4Health News:Many Patients Stop Taking Cholesterol-Lowering Drugs 2Health News:Dilon Technologies Explores Improvements in Molecular Breast Imaging 2Health News:Dilon Technologies Explores Improvements in Molecular Breast Imaging 3Health News:AMIA's 31st Annual Symposium Opens in Chicago, IL 2Health News:AMIA's 31st Annual Symposium Opens in Chicago, IL 3Health News:New Study - Same Verdict 2Health News:Sneaky Chef's Recipes Make Delicious Debut at Morgan Stanley Children's Hospital 2
... Non-Donor Screen. Vironostika HIV assays provide superior ... testing and confirmation. Vironostika HIV-1 Microelisa ... the detection of antibody to HIV-1 in ... Oral Fluid Vironostika HIV-1 Microelisa System is ...
... Rapid Immunoassay: Uni-Gold Recombigen HIV is a single ... to HIV-1 in plasma, serum and whole blood ... in point of care settings as an aid ... is suitable for use in appropriate multi-test algorithms ...
... an OraSure HIV-1 Oral Specimen Collection Device is ... for HIV-1 antibodies. Testing with the OraSure HIV-1 ... needles and has been shown to be more ... specially treated cotton fiber pad attached to a ...
The Becton™ Colles Fracture Plate has proven clinical outcomes and has excellent patient acceptance compared to external fixation. It provides a cost effective treatment option through a simple...
Medicine Products: